PRIMED-AI: Validation Center (U54 Clinical Trial Not Allowed)

<p><span style="color: rgb(51, 51, 51);">The NIH Common Fund, with other NIH Institutes and Centers (ICs), intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the&nbsp;</span><strong style="color: rgb(51, 51, 51);">Precision Medicine with Artificial Intelligence - Integrating Imaging with Multimodal Data (PRIMED-AI) program, which seeks&nbsp;</strong><span style="color: rgb(51, 51, 51);">to develop innovative, reliable, and cost-effective AI-based tools that integrate clinical imaging with other health data types to enhance personalized medicine for patients with chronic and other health conditions. The program’s&nbsp;</span><strong style="color: rgb(51, 51, 51);">Validation Center initiative will serve&nbsp;</strong><span style="color: rgb(51, 51, 51);">as an independent hub for third party verification, validation, and uncertainty quantification of AI-enabled, image-based, multimodal Clinical Decision Support (CDS) tools through the systematic retesting and harmonization of PRIMED-AI deliverables to comprehensively characterize performance of the CDS tools. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.&nbsp;This NOFO will utilize the U54 activity code. Investigators with expertise and insights into the&nbsp;validation of CDS tools and the confidence bounds and potential failure modes of AI predictions are encouraged to begin to consider applying for this new NOFO.&nbsp;</span></p>